Wound Triggered Synergistic Anti Biofilm Frameworks
Lead Research Organisation:
University of Liverpool
Department Name: Institute of Ageing and Chronic Disease
Abstract
This is in the full application from the commercial partner lead
Technical Summary
This is in the application from the commercial partner lead
Planned Impact
This is in the application from the commercial partner lead
Organisations
| Description | We have filed a patent on Anti-microbial Compositions PCT/GB2017/051243 published 9/11/17 that uses the antimicrobial properties of some metals to provide antimicrobial materials for wound dressings. |
| Exploitation Route | These invention could be used in wound dressings and food packaging and would provide an alternative to antibiotics in many situations. |
| Sectors | Healthcare,Manufacturing, including Industrial Biotechology,Pharmaceuticals and Medical Biotechnology |
| Description | The lead company have significantly raised their profile and reputation in their field by conducting this research project with the University of Liverpool. This project has clearly demonstrated the company are research active. |
| First Year Of Impact | 2016 |
| Sector | Healthcare,Manufacturing, including Industrial Biotechology |
| Impact Types | Economic |
| Title | ANTI-MICROBIAL COMPOSITIONS |
| Description | A metal-EDTA compound/complex for combatting biofilms and/or treating wounds. The compound/complex comprises EDTA and from two to four metal ions. Of those two to four metal ions, at least two are different metal ions selected from Ag, Al, Au, Ba, Bi, Tl, Ce, Co, Cu,Fe, Ga, Ir, Mo,Rh, Ru, Ti, and Zn ions. The metal-EDTA compound/complex may exhibit any one or more of anti-microbial, anti-biofilm and anti-inflammatory activities in use and may increase the susceptibility of a biofilm and the microorganisms within said biofilmto attack by anti-microbial agents, helping to remove and sanitise the biofilm. A composition, wound dressing and medical device comprising the metal-EDTA complex are also provided. Uses of the metal-EDTA compound/complex as a medicament and/or to sanitise and/or substantially remove a biofilm from a substrate are also disclosed. |
| IP Reference | WO2017191453 |
| Protection | Patent application published |
| Year Protection Granted | 2017 |
| Licensed | Commercial In Confidence |
| Impact | Awaiting exploitation in new wound dressings |